{"title":"乙醇酸淀粉钠交联强度的定量测定及其对片剂崩解溶出的影响","authors":"Pauline H.M. Janssen , Willem Rijpkema , Kathleen Stout , Marlijn Orbons , Arpan Patel , Bastiaan H.J. Dickhoff","doi":"10.1016/j.ejpb.2025.114803","DOIUrl":null,"url":null,"abstract":"<div><div>The development of a robust oral solid dosage form requires knowledge of all the sources of variation that could impact the dosage form’s performance and stability, in line with Quality-by-Design (QbD). This requires a deep understanding of the relationships between raw material properties, the process parameters and the final product quality. This paper presents<!--> <!-->a method to quantify the strength of cross-links (SXL) in SSG grades by comparing the sediment volume of precipitation after gelling before and after exposure to alkaline conditions. It is demonstrated that SSG grades with phosphorous cross-links are more resistant to hydrolysis than ester cross-links. The developed method can help formulators to assess the SXL of SSG before use in a formulation. The SXL was quantified for seven marketed SSG grades, showing a clear difference between SSG grades with phosphorous cross-links (SXL ≈ 1) and ester cross-links (SXL 0.4 – 0.7). The tablet disintegration and API dissolution of these SSG grades were evaluated for a wet granulation formulation with atenolol. Results show that all SSG grades with phosphorous cross-links realized 80 % atenolol dissolution within 25 min, whereas all grades with ester cross-links reached this threshold only after 45 min or more. This shows that the type of cross-link is a critical attribute that can result in dissolution success or failure. An excellent correlation was observed between the SXL and the time at which 80 % of the atenolol was dissolved. The findings of this study show that understanding the type of cross-link and the SXL of SSG can support formulators with the development of good, robust formulations, in line with a quality-by-design approach. The provided case study shows that formulators can make their formulations more robust to stress exposure before, during or after tablet manufacturing by using an SSG grade with phosphorous cross-links, thereby limiting the risk of product failure.</div></div>","PeriodicalId":12024,"journal":{"name":"European Journal of Pharmaceutics and Biopharmaceutics","volume":"214 ","pages":"Article 114803"},"PeriodicalIF":4.3000,"publicationDate":"2025-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Quantifying cross-linking strength in sodium starch glycolate and its impact on tablet disintegration and dissolution\",\"authors\":\"Pauline H.M. Janssen , Willem Rijpkema , Kathleen Stout , Marlijn Orbons , Arpan Patel , Bastiaan H.J. Dickhoff\",\"doi\":\"10.1016/j.ejpb.2025.114803\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>The development of a robust oral solid dosage form requires knowledge of all the sources of variation that could impact the dosage form’s performance and stability, in line with Quality-by-Design (QbD). This requires a deep understanding of the relationships between raw material properties, the process parameters and the final product quality. This paper presents<!--> <!-->a method to quantify the strength of cross-links (SXL) in SSG grades by comparing the sediment volume of precipitation after gelling before and after exposure to alkaline conditions. It is demonstrated that SSG grades with phosphorous cross-links are more resistant to hydrolysis than ester cross-links. The developed method can help formulators to assess the SXL of SSG before use in a formulation. The SXL was quantified for seven marketed SSG grades, showing a clear difference between SSG grades with phosphorous cross-links (SXL ≈ 1) and ester cross-links (SXL 0.4 – 0.7). The tablet disintegration and API dissolution of these SSG grades were evaluated for a wet granulation formulation with atenolol. Results show that all SSG grades with phosphorous cross-links realized 80 % atenolol dissolution within 25 min, whereas all grades with ester cross-links reached this threshold only after 45 min or more. This shows that the type of cross-link is a critical attribute that can result in dissolution success or failure. An excellent correlation was observed between the SXL and the time at which 80 % of the atenolol was dissolved. The findings of this study show that understanding the type of cross-link and the SXL of SSG can support formulators with the development of good, robust formulations, in line with a quality-by-design approach. The provided case study shows that formulators can make their formulations more robust to stress exposure before, during or after tablet manufacturing by using an SSG grade with phosphorous cross-links, thereby limiting the risk of product failure.</div></div>\",\"PeriodicalId\":12024,\"journal\":{\"name\":\"European Journal of Pharmaceutics and Biopharmaceutics\",\"volume\":\"214 \",\"pages\":\"Article 114803\"},\"PeriodicalIF\":4.3000,\"publicationDate\":\"2025-06-27\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European Journal of Pharmaceutics and Biopharmaceutics\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0939641125001808\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Pharmaceutics and Biopharmaceutics","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0939641125001808","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
Quantifying cross-linking strength in sodium starch glycolate and its impact on tablet disintegration and dissolution
The development of a robust oral solid dosage form requires knowledge of all the sources of variation that could impact the dosage form’s performance and stability, in line with Quality-by-Design (QbD). This requires a deep understanding of the relationships between raw material properties, the process parameters and the final product quality. This paper presents a method to quantify the strength of cross-links (SXL) in SSG grades by comparing the sediment volume of precipitation after gelling before and after exposure to alkaline conditions. It is demonstrated that SSG grades with phosphorous cross-links are more resistant to hydrolysis than ester cross-links. The developed method can help formulators to assess the SXL of SSG before use in a formulation. The SXL was quantified for seven marketed SSG grades, showing a clear difference between SSG grades with phosphorous cross-links (SXL ≈ 1) and ester cross-links (SXL 0.4 – 0.7). The tablet disintegration and API dissolution of these SSG grades were evaluated for a wet granulation formulation with atenolol. Results show that all SSG grades with phosphorous cross-links realized 80 % atenolol dissolution within 25 min, whereas all grades with ester cross-links reached this threshold only after 45 min or more. This shows that the type of cross-link is a critical attribute that can result in dissolution success or failure. An excellent correlation was observed between the SXL and the time at which 80 % of the atenolol was dissolved. The findings of this study show that understanding the type of cross-link and the SXL of SSG can support formulators with the development of good, robust formulations, in line with a quality-by-design approach. The provided case study shows that formulators can make their formulations more robust to stress exposure before, during or after tablet manufacturing by using an SSG grade with phosphorous cross-links, thereby limiting the risk of product failure.
期刊介绍:
The European Journal of Pharmaceutics and Biopharmaceutics provides a medium for the publication of novel, innovative and hypothesis-driven research from the areas of Pharmaceutics and Biopharmaceutics.
Topics covered include for example:
Design and development of drug delivery systems for pharmaceuticals and biopharmaceuticals (small molecules, proteins, nucleic acids)
Aspects of manufacturing process design
Biomedical aspects of drug product design
Strategies and formulations for controlled drug transport across biological barriers
Physicochemical aspects of drug product development
Novel excipients for drug product design
Drug delivery and controlled release systems for systemic and local applications
Nanomaterials for therapeutic and diagnostic purposes
Advanced therapy medicinal products
Medical devices supporting a distinct pharmacological effect.